IDACIO Trademark

Trademark Overview


On Thursday, April 21, 2022, a trademark application was filed for IDACIO with the United States Patent and Trademark Office. The USPTO has given the IDACIO trademark a serial number of 97373891. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Fresenius Kabi Deutschland GmbH. The IDACIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases...
idacio

General Information


Serial Number97373891
Word MarkIDACIO
Filing DateThursday, April 21, 2022
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7177855
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis; Pharmaceutical preparations for treating a wide variety of autoimmune diseases, illnesses and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code005
First Use Anywhere DateSaturday, July 1, 2023
First Use In Commerce DateSaturday, July 1, 2023

Trademark Owner History


Party NameFresenius Kabi Deutschland GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Party NameFresenius Kabi Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Party NameFresenius Kabi Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 2, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, July 14, 2023USE AMENDMENT FILED
Wednesday, August 2, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 14, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 12, 2022NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, July 12, 2022PRIORITY ACTION E-MAILED
Tuesday, July 12, 2022PRIORITY ACTION WRITTEN
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 25, 2022NEW APPLICATION ENTERED